RVVC patients currently having the disease (≥4 acute episodes during past 12 months)
n=620
RVVC patients having acute episode on day of
questionnaire completion
(FR, IT, SP,GER, US)
n=30
EQ-5D asked for
day of quest.
completion
(acute episode)
n= 30
Utility = 0.64
EQ-5D asked for
other days
(between episodes)
n=30
Utility = 0.84
RVVC patients between acute episodes on day
of questionnaire completion
(FR, IT, SP, GER, US)
n=490
EQ-5D asked for day
of quest.
Completion,
(between episodes)
n=490
Utility = 0.69
RVVC patients on day of
questionnaire completion
in UK
n=100
EQ-5D asked for
other days
(acute episode)
EQ-5D asked for day of
quest. Completion
n=490
Utility = 0.50
n=100
Utility = 0.74
EQ-5D between episodes
N=520
Utility = 0.70
EQ-5D acute episodes
N=520
Utility = 0.51
RVVC patients on the day of questionnaire completion
n=620
Utility = 0.70